$28.87
+0.81
(+2.89%)
As of Oct 5, 2026, 4:19 PM EDT
Price history
Acadia Healthcare (ACHC) is trading up at $28.87 (+2.89%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Acadia Healthcare revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.81B | $2.84B | $1.90B | $2.01B | $2.09B | $2.31B | $2.61B | $2.93B | $3.15B | $3.31B |
| Growth (year over year) | — | +0.9% | −32.8% | +5.4% | +4.1% | +10.7% | +12.8% | +12.2% | +7.7% | +5.0% |
| Operating income | $608.6M | $604.4M | $593.6M | $585.9M | — | — | — | — | — | — |
| Operating margin | 21.7% | 21.3% | 31.2% | 29.2% | — | — | — | — | — | — |
| Net income | $6.14M | $199.8M | −$175.8M | $108.9M | −$672.1M | $190.6M | $273.1M | −$21.7M | $255.6M | −$1.10B |
| Net margin | 0.2% | 7.0% | −9.2% | 5.4% | −32.2% | 8.2% | 10.5% | −0.7% | 8.1% | −33.3% |
| EPS (diluted) | $0.07 | $2.30 | −$2.01 | $1.24 | −$7.59 | $2.10 | $2.98 | −$0.24 | $2.78 | −$12.16 |
| Balance sheet | ||||||||||
| Cash and equivalents | $57.1M | $67.3M | $50.5M | $99.5M | $378.7M | $133.8M | $97.6M | $100.1M | $76.3M | $133.2M |
| Total assets | $6.02B | $6.42B | $6.17B | $6.88B | $6.50B | $4.77B | $4.99B | $5.36B | $5.96B | $5.53B |
| Total liabilities | $3.84B | $3.83B | $3.81B | $4.34B | $4.54B | $2.19B | $2.09B | $2.47B | $2.77B | $3.39B |
| Long-term debt | $3.25B | $3.21B | $3.16B | $3.11B | $2.97B | $1.48B | $1.36B | $1.34B | $1.88B | $2.47B |
| Shareholders' equity | $2.17B | $2.57B | $2.33B | $2.51B | $1.90B | $2.52B | $2.81B | $2.78B | $3.07B | $1.95B |
| Cash flow | ||||||||||
| Operating cash flow | $361.5M | $399.6M | $414.1M | $332.9M | $658.8M | $374.5M | $380.6M | $462.3M | $129.7M | $131.9M |
| Capital expenditure | $307.5M | $274.2M | $253.2M | $232.7M | $225.0M | $244.8M | $296.1M | $424.1M | $690.4M | $571.8M |
| Free cash flow | $54.0M | $125.4M | $160.9M | $100.2M | $433.8M | $129.7M | $84.4M | $38.2M | −$560.7M | −$439.9M |
| Share buybacks | — | — | — | — | — | — | — | — | — | $50.0M |
RevenueNet income
| Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $796.0M | $815.6M | $774.2M | $770.5M | $869.2M | $851.6M | $821.5M | $828.8M |
| Growth (year over year) | +8.8% | +8.7% | +4.2% | +0.3% | +9.2% | +4.4% | +6.1% | +7.6% |
| Net income | $78.5M | $68.1M | $32.6M | $8.37M | $30.1M | $36.2M | −$1.18B | $4.11M |
| Net margin | 9.9% | 8.4% | 4.2% | 1.1% | 3.5% | 4.3% | −143.3% | 0.5% |
| EPS (diluted) | $0.85 | $0.74 | $0.36 | $0.09 | $0.33 | $0.40 | −$12.98 | $0.05 |
| Balance sheet | ||||||||
| Cash and equivalents | $77.2M | $82.1M | $76.3M | $91.2M | $131.4M | $118.7M | $133.2M | $158.5M |
| Total assets | $5.68B | $5.87B | $5.96B | $6.15B | $6.31B | $6.41B | $5.53B | $5.55B |
| Total liabilities | $2.61B | $2.72B | $2.77B | $2.97B | $3.08B | $3.12B | $3.39B | $3.38B |
| Long-term debt | $1.77B | $1.80B | $1.88B | $2.18B | $2.25B | $2.28B | $2.47B | $2.49B |
| Shareholders' equity | $2.95B | $3.03B | $3.07B | $3.04B | $3.08B | $3.12B | $1.95B | $1.96B |
| Cash flow | ||||||||
| Operating cash flow | $171.1M | $163.1M | $116.7M | $11.5M | $133.5M | $73.2M | −$86.3M | $61.5M |
| Capital expenditure | $154.2M | $190.2M | $203.5M | $174.6M | $167.7M | $136.2M | $93.2M | $76.6M |
| Free cash flow | $16.9M | −$27.1M | −$86.8M | −$163.2M | −$34.2M | −$63.0M | −$179.5M | −$15.0M |
| Share buybacks | — | — | — | $46.9M | $3.15M | $0 | $0 | — |
From Acadia Healthcare's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Acadia Healthcare
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Source: Wikipedia — Acadia Healthcare
- Headquarters
- Franklin, Tennessee From SEC filings, Oct 2026
Recent News
No recent news mentioning Acadia Healthcare in our feed yet.
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International